Yibin Deng

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Systemic Sclerosis

Top Venues

Nature communications

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ting Li, Shuhui Jiang, Ying Zhang, Jie Luo, Ming Li, Hengte Ke, Yibin Deng, Tao Yang, Xiaohui Sun, Huabing Chen
Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation. Nature communications 14 (1) (2023)
Ting Li, Shuhui Jiang, Ying Zhang, Jie Luo, Ming Li, Hengte Ke, Yibin Deng, Tao Yang, Xiaohui Sun, Huabing Chen
Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation. Nature communications 14 (1) (2023)
Ting Li, Shuhui Jiang, Ying Zhang, Jie Luo, Ming Li, Hengte Ke, Yibin Deng, Tao Yang, Xiaohui Sun, Huabing Chen
Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation. Nature communications 14 (1) (2023)
Yaoqi Li, Jie Zhu, Yifan Yang, Yitian Chen, Lishan Liu, Jing Tao, Huabing Chen, Yibin Deng
Long-Acting Nanohybrid Hydrogel Induces Persistent Immunogenic Chemotherapy for Suppressing Postoperative Tumor Recurrence and Metastasis. Molecular pharmaceutics (2023)